H.R. 8698 · 118th Congress · Health

SCREEN for Type 1 Diabetes Act of 2024

Died in committee863 words Introduced Jun 11, 2024 · Latest action Jun 11, 2024

How far it has goneStopped at 2 of 6 · Died in committee
  1. IntroducedJun 11, 2024 Done
  2. CommitteeDied Jan 3, 2025 Stopped here
  3. House floorNot yet Not reached yet
  4. Senate floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

The Congressional Research Service hasn’t published a summary of this bill. Read the full text on Congress.gov.

Who lobbies on it

1 organization · 2 filings · Q2 2024–Q4 2024

See which of this bill’s sponsors and cosponsors got money from Sanofi Us Services Inc’s PAC → Pro

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. Sanofi Us Services Inc 2 of 3 quarters
    “…issues related to HR 8698 and S.4504 "SCREEN for Type 1 Diabetes"; issues related to HRSA - Type 1 Diabetes Screening; general issues related to Inflation Reduction Act; issues related to March-In rights; and issues related to Routine Immunizations Rates.”

    $5.5M lobbying spend in 2024, all issuesQ3 2024 filing

Organizations that named H.R. 8698 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

2 actions · newest first
  1. Jun 11, 2024Referred to the House Committee on Energy and Commerce.
  2. Jun 11, 2024Introduced in House